An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHuiping Shuai, Hin Chu, Xiaoyan Xia et al.|Nature Communications|2025Cited by 8
Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHuiping Shuai, Hin Chu, Jie Zhou et al.|Nature Communications|2025Cited by 0